Furthermore, on the same reasoning, many studies in NSCLC are recently addressing the prognostic value of other key proteins or gene involved in glucose metabolism, e.g. GLUT1, HK2 [10]. The gene discussed is SLC2A1; the disease is non-small cell lung carcinoma.